PEB I already own this as a long term investment, but interesting chart right now....
Currently had gap down due to bad Medicare news removing product from approved test list, but shortly afterwards one product was ranked highest A+ for test credibility so this may remove the previous restriction in Medicare and open market again
Technically this has a long term Elliott Wave 'Ending Diagonal' with an overthrow pattern which is technically a reversal signal, this was followed by a strong move upwards following the results of an industry comparison of products which proved very positive
Currently the Triangle has been broken and now being retested, and is now at a good point to hopefully go higher... it may need a news/ medicare catalyst, but the probability is that it is more likely technically and fundamentally to rise than to fall...
Moving from current $0.126 to $0.42 will be a 333% Return from current levels
And there are gap closes at $0.49 and $0.78c so this represents a high potential reward to risk trade
Currently had gap down due to bad Medicare news removing product from approved test list, but shortly afterwards one product was ranked highest A+ for test credibility so this may remove the previous restriction in Medicare and open market again
Technically this has a long term Elliott Wave 'Ending Diagonal' with an overthrow pattern which is technically a reversal signal, this was followed by a strong move upwards following the results of an industry comparison of products which proved very positive
Currently the Triangle has been broken and now being retested, and is now at a good point to hopefully go higher... it may need a news/ medicare catalyst, but the probability is that it is more likely technically and fundamentally to rise than to fall...
Moving from current $0.126 to $0.42 will be a 333% Return from current levels
And there are gap closes at $0.49 and $0.78c so this represents a high potential reward to risk trade
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.